P160050/S012: Barricaid Annular Closure Device
FDA’s recorded scope: approval for an alternate manufacturing process and new supplier affecting critical components of the Barricaid implant device/delivery system, specifically the 8mm Delivery Sheath
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 3 FDA records to the applicant name Intrinsic Therapeutics. 1 entry is a PMA supplement. 2 entries are 30-day notices. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Oct 9, 2025 to Mar 24, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code QES appears in 3 of the 3 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P160050, with 3 linked entries. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 30 Commerce Way, Woburn, MA, 01801. Recorded on P160050/S012, decision dated Mar 24, 2026.
FDA’s recorded scope: approval for an alternate manufacturing process and new supplier affecting critical components of the Barricaid implant device/delivery system, specifically the 8mm Delivery Sheath
FDA’s recorded scope: approval for manufacturing process changes to the delivery instrument of the Barricaid Annular Closure Device
FDA’s recorded scope: approval for a new 6mm baseplate sized implant.
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
Barricaid Annular Closure DeviceP160050/S012 | Intrinsic Therapeutics | PMA supplement | Mar 24, 2026 | FDA |
Barricaid Annular Closure DeviceP160050/S011 | Intrinsic Therapeutics | PMA supplement | Dec 18, 2025 | FDA |
Barricaid Annular Closure DeviceP160050/S010 | Intrinsic Therapeutics | PMA supplement | Oct 9, 2025 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 21, 2026.